New York, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Gliosarcoma Drugs in Development by Stages, Target, MoA, RoA ...
Gliosarcoma is a rare type of cancerous tumor that develops in the central nervous system (CNS). It grows in the brain or spinal cord and can affect functions such as movement and memory. Tumors that ...
Please provide your email address to receive an email when new articles are posted on . A 23-year-old female with no significant medical history developed a headache. On the evening of the following ...
Optimal treatment sequence for untreated EGFR-mutant NSCLC with brain metastases. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This abstract does not include a full text ...
April 30, 2012 (Miami, Florida) — The use of bevacizumab to treat recurrent glioblastoma multiforme (GBM) may raise the risk for secondary gliosarcoma (GS). Bevacizumab (Avastin, Genentech), an ...
Dublin, April 02, 2026 (GLOBE NEWSWIRE)-- The "Gliosarcoma Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights, covering global market ...
Few reported cases of gliosarcomas or glioblastomas with epithelial-like areas exist. Most cases were originally diagnosed as metastatic carcinoma. Focal expression of glial fibrillary acidic protein ...
Adjuvant temozolomide therapy at continuous low dose after first relapse in patients with glioblastoma multiforme treated initially with radiation plus standard-dose temozolomide: report of two cases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results